Advertisement

Topics

Should A Biosimilar Sponsor Do The 'Patent Dance?' It Depends On Many Things

12:59 EDT 22 Aug 2017 | SCRIP

The amount of exclusivity remaining for a reference product, strength of an innovator's patents and risk of a preliminary injunction...

      

Related Stories

 

Original Article: Should A Biosimilar Sponsor Do The 'Patent Dance?' It Depends On Many Things

NEXT ARTICLE

More From BioPortfolio on "Should A Biosimilar Sponsor Do The 'Patent Dance?' It Depends On Many Things"

Advertisement
Quick Search
Advertisement
Advertisement